ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,836Medicare Part D Prescriptions Filled, Including Refills

Rank: 359 out of 3593

$1.52M Total Retail Price of All Prescriptions

Rank: 47 out of 3593

605 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,790 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$118 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NEXIUM 377 274 1 36
OMEPRAZOLE 367 311 2 5
LISINOPRIL 346 288 3 2
CRESTOR 334 257 4 21
PLAVIX 321 235 5 42
LIDODERM 298 187 6 78
ADVAIR DISKUS 280 198 7 47
AMLODIPINE BESYLATE 260 218 8 3
NAMENDA 251 195 9 50
SIMVASTATIN 241 213 10 1
DIOVAN 237 207 11 46
SINGULAIR 231 146 12 77
METFORMIN HCL 213 160 13 6
CLOPIDOGREL 194 152 14 30
FUROSEMIDE 193 179 15 9
CELEBREX 188 124 16 100
METOPROLOL TARTRATE 171 134 17 8
VOLTAREN 164 118 18 85
LEVOTHYROXINE SODIUM 159 126 19 4
IBUPROFEN 157 125 20 43
EXELON 139 72 21 123
LYRICA 137 92 22 105
ESCITALOPRAM OXALATE 132 114 23 71
ABILIFY 124 67 24 162
LEXAPRO 122 85 25 184
POTASSIUM CHLORIDE 121 112 26 24
CARVEDILOL 113 87 27 23
ATENOLOL 110 91 28 11
AZITHROMYCIN 110 86 28 34
WARFARIN SODIUM 109 105 30 18
LANTUS 105 86 31 57
GABAPENTIN 98 75 32 16
NASONEX 98 62 32 192
CLONIDINE HCL 97 88 34 41
DOVONEX 95 61 35 304
NOVOLIN 70-30 93 81 36 146
RANITIDINE HCL 92 60 37 27
HYDROCHLOROTHIAZIDE 89 61 38 10
FLUTICASONE PROPIONATE 88 74 39 32
PROAIR HFA 86 70 40 54
DIOVAN HCT 86 65 40 76
DONEPEZIL HCL 80 57 42 31
INSULIN SYRINGE 77 73 43 91
SEROQUEL 75 39 44 172
ATORVASTATIN CALCIUM 72 58 45 15
ZOLPIDEM TARTRATE 70 56 46 12
ENALAPRIL MALEATE 70 61 46 38
HYDROCORTISONE 69 52 48 273
METOPROLOL SUCCINATE 69 57 48 19
CYMBALTA 68 37 50 73
DICLOFENAC SODIUM 67 48 51 74
GLIPIZIDE 65 46 52 40
NITROGLYCERIN PATCH 65 60 52 212
ISOSORBIDE MONONITRATE ER 65 54 52 61
TRAMADOL HCL 64 29 55 17
SYMBICORT 60 41 56 160
TRICOR 60 31 56 130
BENAZEPRIL HCL 60 60 56 69
ACTOS 59 48 59 133
ZYPREXA 59 27 59 417
LOSARTAN POTASSIUM 59 48 59 14
QUETIAPINE FUMARATE 58 40 62 89
GEODON 56 22 63 409
LOVAZA 55 33 64 106
LIPITOR 54 30 65 136
MUPIROCIN 53 40 66 132
PANTOPRAZOLE SODIUM 53 52 66 45
SURE COMFORT 52 46 68 159
MEGACE ES 52 27 R 68 373
DIGOXIN 51 51 70 58
JANUVIA 50 29 71 81
LEVOFLOXACIN 50 49 71 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.